Biocon Limited declares final dividend of ₹0.50 per share for FY26
Biocon Limited declared a final dividend of ₹0.50 per equity share for FY 2025-26. This was approved at the 48th AGM on August 6, 2026. The record date was July 3, 2026. Dividend remittance has commenced via electronic mode.
Dividend announcements are important for investors but typically have a moderate impact on the company's stock price unless the amount is unusually large or small compared to expectations.
The announcement of a dividend payment is generally viewed positively by shareholders as it represents a return on their investment.
Biocon Limited has announced the remittance of its final dividend for the financial year 2025-26. The dividend of ₹0.50 per equity share, with a face value of ₹5, was approved by the company's members at the 48th Annual General Meeting (AGM) held on Thursday, August 06, 2026. The record date for determining the eligible shareholders was Friday, July 03, 2026. The company has remitted the dividend amount through electronic mode to shareholders who have registered their bank details with the Registrar & Share Transfer Agent or Depository Participants. Shareholders who have not registered their email IDs will receive a physical communication. The dividend details will also be available on Biocon's website. Shareholders are advised to verify the credit in their bank accounts and contact KFin Technologies Limited, the Registrar & Share Transfer Agent, in case of any issues.
KFin Technologies Limited, located at Selenium, Tower B, Plot Nos. 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad - 500032, India, can be contacted for any dividend-related queries. The company secretary and compliance officer, Rajesh U. Shanoy, has signed off on the communication.
What to do with a filing like this
Biocon Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.